How Does Vivitrol Work for Alcohol and Opioids?

Vivitrol is a once-monthly injection that blocks opioid receptors in the brain, removing the rewarding effects of alcohol and opioids. The active ingredient, naltrexone, sits on the same receptors that alcohol and opioids use to produce a “high,” effectively acting as a lock that keeps those substances from turning on the brain’s pleasure signals. It’s FDA-approved for treating alcohol dependence and preventing relapse to opioid dependence after detox.

How It Blocks Opioids

Naltrexone works by competing with opioids for access to mu-opioid receptors, the primary docking sites in the brain responsible for the euphoria and pain relief opioids produce. When naltrexone occupies these receptors, opioids like heroin, fentanyl, or prescription painkillers can’t bind to them. The result: if you use an opioid while on Vivitrol, you won’t feel the high. There’s no euphoria, no rush, no reinforcement that drives continued use. Naltrexone also blocks kappa and delta opioid receptors to a lesser degree, though the mu receptor blockade does most of the heavy lifting.

This is different from medications like methadone or buprenorphine, which partially activate opioid receptors to reduce cravings and withdrawal. Naltrexone is a pure antagonist. It doesn’t activate anything. It simply blocks.

How It Reduces Alcohol Cravings

The connection between opioid receptors and alcohol is less obvious but well established. When you drink, your brain releases its own natural opioids (endorphins), which then trigger a surge of dopamine in the brain’s reward center. That dopamine rush is what makes alcohol feel pleasurable and reinforces the desire to keep drinking.

Naltrexone interrupts this chain at two points. First, it blocks endorphins from stimulating dopamine release directly in the reward center. Second, it prevents endorphins from disabling a separate braking system that normally keeps dopamine levels in check. With both pathways disrupted, alcohol simply doesn’t feel as rewarding. Many people on Vivitrol describe being able to have a drink placed in front of them and feeling genuinely indifferent to it. The compulsive pull weakens because the neurochemical payoff is no longer there.

The Monthly Injection Format

Naltrexone also comes as a daily pill, but Vivitrol’s advantage is its delivery system. Each injection contains 380 mg of naltrexone suspended in a slow-dissolving polymer. A healthcare provider injects it into the gluteal muscle (the buttock) once every four weeks, and the medication releases steadily over that month.

This solves one of the biggest problems in addiction treatment: adherence. With a daily pill, a person can simply stop taking it when cravings intensify or when they decide they want to use. With a monthly injection, the medication keeps working regardless of willpower or motivation on any given day. That said, real-world adherence remains a challenge. A systematic review found that about 44% of patients completed all their scheduled injections, which typically meant six doses or fewer. Adherence was notably higher in structured treatment programs compared to routine clinical care.

What You Need Before Starting

Vivitrol has strict prerequisites, especially for opioid dependence. You must be completely opioid-free for a minimum of 7 to 14 days before your first injection. This includes street drugs, prescription painkillers, cough and cold medicines containing opioids, and opioid-based treatments like methadone or buprenorphine. If any opioids are still in your system when the injection is given, the naltrexone will immediately displace them from your receptors, triggering what’s called precipitated withdrawal. This is sudden, severe withdrawal that can require hospitalization.

For alcohol dependence, the requirement is less dramatic but still important: you should not be actively drinking at the time of your first dose. Vivitrol is designed for people who have already achieved initial abstinence and need help maintaining it. In both cases, the FDA label specifies that Vivitrol should be part of a broader treatment program that includes counseling or other psychosocial support.

Getting Started Can Be the Hardest Part

For people with opioid dependence, that required opioid-free period creates a real barrier. You essentially need to go through detox and endure 7 to 14 days without opioids before protection kicks in. Research reflects this difficulty: among people who still needed detoxification, only about 63% successfully started Vivitrol. Among those who were already detoxified, the success rate for getting that first injection jumped to 85%.

This gap matters because those first days without opioids are when relapse risk is highest, and the medication can’t help until it’s on board. Some treatment programs offer medically supervised detox specifically designed to bridge patients to their first Vivitrol injection.

The Overdose Risk Most People Don’t Know About

Vivitrol creates a paradox that’s important to understand. While the medication blocks opioid effects and reduces use, it also lowers your body’s tolerance to opioids over time. If you attempt to override the blockade by taking very large amounts of opioids, you risk respiratory depression, coma, or death. The blockade is strong, but it is not absolute at extreme doses.

The more dangerous window, though, comes after treatment ends. Once the medication wears off, your opioid receptors are unblocked, but your tolerance has dropped significantly. Animal studies suggest that naltrexone may actually increase the number of opioid receptors in the brain, potentially making you more sensitive to opioids than you were before treatment. Research has identified a roughly one-month window after the last injection during which the risk of opioid overdose is particularly high. If you stop Vivitrol and return to opioid use at the doses you previously tolerated, the results can be fatal.

Common Side Effects

Because Vivitrol is injected into muscle tissue, reactions at the injection site are among the most frequently reported issues. These can range from mild tenderness and redness to harder lumps or nodules that take weeks to resolve. Nausea is also common, particularly after the first injection, and tends to improve with subsequent doses.

Other reported side effects include headaches, fatigue, dizziness, and decreased appetite. Because naltrexone is processed by the liver, liver function is monitored during treatment. Most people tolerate the injection well, but the side effect profile is worth discussing with your provider before starting, especially if you have existing liver concerns.

What the Treatment Experience Looks Like

In practice, Vivitrol treatment is straightforward. You visit a clinic or provider’s office once a month for an injection. Between visits, the medication works continuously in the background. You don’t take anything daily. You don’t experience withdrawal symptoms from the medication itself if you stop, though you lose the protective blockade.

The medication doesn’t eliminate cravings entirely for everyone, and it doesn’t address the psychological, social, or environmental factors that drive addiction. That’s why it works best alongside therapy, support groups, or other structured treatment. Think of it as removing the neurochemical reward that makes substances so hard to resist, giving you a clearer head to do the harder work of recovery.